Pioneer in phage-based diagnostics

01359 231856

Twitter Youtube Linkedin Envelope
  • Home
  • About
    • About PBD Biotech
    • Leadership
    • Blog
  • Latest
    • Press releases
    • In the news
    • Events
  • Actiphage TB
    • What is Actiphage TB?
    • Unique role in TB testing
    • Supporting test and treat campaigns
    • Clinical studies
  • Lab Support
    • Laboratory Support
    • Solutions for laboratory developed tests
    • Actiphage assay workflow
    • Instructions for use of Actiphage
  • TB Drug Research
    • TB drug research
    • Research Use Only
    • Biomarker for TB prevention
  • Contact
    • Contacting us
    • Partnerships and collaborations
Menu
  • Home
  • About
    • About PBD Biotech
    • Leadership
    • Blog
  • Latest
    • Press releases
    • In the news
    • Events
  • Actiphage TB
    • What is Actiphage TB?
    • Unique role in TB testing
    • Supporting test and treat campaigns
    • Clinical studies
  • Lab Support
    • Laboratory Support
    • Solutions for laboratory developed tests
    • Actiphage assay workflow
    • Instructions for use of Actiphage
  • TB Drug Research
    • TB drug research
    • Research Use Only
    • Biomarker for TB prevention
  • Contact
    • Contacting us
    • Partnerships and collaborations

Blog

Latest news and views from PBD Biotech about the detection, identification and eradication of tuberculosis and related mycobacterial diseases.

Loading...
42Plus1 at DxPx 2023

5 October 2023

PBD Biotech finalists for 42plus1 pitch event at DxPx EU

September 26, 2023
PBD Biotech is one of the finalists selected to participate in the 42plus1 pitch event at DxPx EU in Munich, Germany on the 5th October 2023. This follows our participation in DxPx US.
42Plus1 at DxPx 2023

5 October 2023

PBD Biotech finalists for 42plus1 pitch event at DxPx EU

September 26, 2023
PBD Biotech is one of the finalists selected to participate in the 42plus1 pitch event at DxPx EU in Munich,...
Mycobacterium tuberculosis (from CDC) transmission-reducing effects

Could phage-based TB diagnostics determine transmission-reducing benefits of vaccines in phase 3 trials?

September 19, 2023
Conventional phase 3 trials do not provide key information about the overall effect of introducing a new tuberculosis vaccine programme and so are missing crucial information for policy makers, argue experts in a personal view in Lancet Microbe.
Mycobacterium tuberculosis (from CDC) transmission-reducing effects

Could phage-based TB diagnostics determine transmission-reducing benefits of vaccines in phase 3 trials?

September 19, 2023
Conventional phase 3 trials do not provide key information about the overall effect of introducing a new tuberculosis vaccine programme...
Maggie Throup MP (credit: Richard Townshend / House of Commons)

Maggie Throup MP, chair of Diagnostics APPG, to meet leading UK diagnostic companies

September 13, 2023
PBD Biotech is one of the companies represented at a parliamentary reception organised by the British In Vitro Diagnostics Association (BIVDA)
Maggie Throup MP (credit: Richard Townshend / House of Commons)

Maggie Throup MP, chair of Diagnostics APPG, to meet leading UK diagnostic companies

September 13, 2023
PBD Biotech is one of the companies represented at a parliamentary reception organised by the British In Vitro Diagnostics Association...
Investival Showcase 2023

Monday 13 November 2023

Actiphage biomarker for TB disease progression features in Inv€$tival Showcase

August 25, 2023
The Inv€$tival Showcase in Old Billingsgate, London, is part of Europe’s biggest healthcare investment week. It will feature Actiphage TB, a groundbreaking diagnostic for tuberculosis.
Investival Showcase 2023

Monday 13 November 2023

Actiphage biomarker for TB disease progression features in Inv€$tival Showcase

August 25, 2023
The Inv€$tival Showcase in Old Billingsgate, London, is part of Europe’s biggest healthcare investment week. It will feature Actiphage TB,...
Actiphage TB awarded US Patent grant for diagnostic kit

Actiphage TB awarded US Patent grant for diagnostic kit

July 25, 2023
PBD Biotech, developers of Actiphage® TB, a ground-breaking phage-based diagnostic for laboratory tuberculosis testing, has today announced it has secured the grant of a US patent for its diagnostic kit.
Actiphage TB awarded US Patent grant for diagnostic kit

Actiphage TB awarded US Patent grant for diagnostic kit

July 25, 2023
PBD Biotech, developers of Actiphage® TB, a ground-breaking phage-based diagnostic for laboratory tuberculosis testing, has today announced it has secured...
Dr Pranab Haldar using novel bacteriophage-based

Novel bacteriophage-based diagnostic for TB enters clinical trial

July 6, 2023
The bacteriophage-based diagnostic may play vital role in detecting TB progression
Dr Pranab Haldar using novel bacteriophage-based

Novel bacteriophage-based diagnostic for TB enters clinical trial

July 6, 2023
The bacteriophage-based diagnostic may play vital role in detecting TB progression
pan North West of England’s Health and Life Sciences Cluster fight-against-infectious-disease

Phage-based diagnostics and the fight against infectious disease

May 22, 2023
PBD Biotech to speak at Liverpool School of Tropical Medicine anniversary celebrations
pan North West of England’s Health and Life Sciences Cluster fight-against-infectious-disease

Phage-based diagnostics and the fight against infectious disease

May 22, 2023
PBD Biotech to speak at Liverpool School of Tropical Medicine anniversary celebrations
Actiphage TB diagnostic releases bacterial DNA for qPCR

16 May 2023

New Centre for Phage Research features Actiphage within Innovation Showcase

May 12, 2023
The UK’s first Centre for Phage Research is being officially launched on 16th May and featured in the UK KTN UK Phage Innovation Showcase will be Actiphage®, a phage-based molecular diagnostic for tuberculosis.
Actiphage TB diagnostic releases bacterial DNA for qPCR

16 May 2023

New Centre for Phage Research features Actiphage within Innovation Showcase

May 12, 2023
The UK’s first Centre for Phage Research is being officially launched on 16th May and featured in the UK KTN...
Actiphage from PBD Biotech offers the potential for a ‘test of cure’ for TB drug treatment

Potential for Actiphage to provide ‘test of cure’ for new TB drugs

April 13, 2023
Accurate and rapid drug resistance testing is essential for early diagnosis of both drug-sensitive and drug-resistant TB.
Actiphage from PBD Biotech offers the potential for a ‘test of cure’ for TB drug treatment

Potential for Actiphage to provide ‘test of cure’ for new TB drugs

April 13, 2023
Accurate and rapid drug resistance testing is essential for early diagnosis of both drug-sensitive and drug-resistant TB.
AACC webinar phage-based TB diagnostics

PBD Biotech announces AACC webinar to support awareness of new TB diagnostics

March 23, 2023
We embrace the World TB day theme 'Yes! We Can End TB' with an educational webinar event on new diagnostic tests that are urgently needed to screen LTBI and determine who will progress to active TB disease.
AACC webinar phage-based TB diagnostics

PBD Biotech announces AACC webinar to support awareness of new TB diagnostics

March 23, 2023
We embrace the World TB day theme 'Yes! We Can End TB' with an educational webinar event on new diagnostic...
AACC webinar phage-based TB diagnostics

19 April 2023

‘We can #EndTB’ – phage-based diagnostics for TB to be discussed at AACC webinar

March 22, 2023
The role of phage-based laboratory diagnostics in the detection of tuberculosis is to be discussed in a live webinar hosted by the AACC, it has been announced ahead of World TB Day.
AACC webinar phage-based TB diagnostics

19 April 2023

‘We can #EndTB’ – phage-based diagnostics for TB to be discussed at AACC webinar

March 22, 2023
The role of phage-based laboratory diagnostics in the detection of tuberculosis is to be discussed in a live webinar hosted...
PCR bead

Novel PCR reaction bead extends global reach of active TB test by removing the cold chain

March 17, 2023
Tuberculosis testing and treatment needs to happen close to the point of infection. PBD Biotech has developed a lyophilized PCR reaction bead for its Actiphage® blood test for active TB. This enables ambient shipping without the need for a cold...
PCR bead

Novel PCR reaction bead extends global reach of active TB test by removing the cold chain

March 17, 2023
Tuberculosis testing and treatment needs to happen close to the point of infection. PBD Biotech has developed a lyophilized PCR...
1 2 … 4 Next »

developers of phage-based diagnostics

Contact Us

Registered Company Address
Grosvenor St Paul’s
Grosvenor House
11 St Paul’s Square
Birmingham
B3 1RB
United Kingdom

T: 01359 231856
info@pbdbio.com

BIVDA member 2023
Twitter Youtube Linkedin

Privacy and cookies policy

© 2022 PBD Biotech Ltd

design: out of house